- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Japanese Classification of Esophageal Cancer, 12th Edition: Part II ; day:21 ; month:3 ; year:2024 ; pages:1-54
Esophagus ; (21.3.2024), 1-54
- Urheber
-
Doki, Yuichiro
Tanaka, Koji
Kawachi, Hiroshi
Shirakawa, Yasuhiro
Kitagawa, Yuko
Toh, Yasushi
Yasuda, Takushi
Watanabe, Masayuki
Kamei, Takashi
Oyama, Tsuneo
Seto, Yasuyuki
Murakami, Kentaro
Arai, Tomio
Muto, Manabu
Mine, Shinji
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10388-024-01048-w
- URN
-
urn:nbn:de:101:1-2405230724535.064563981391
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Doki, Yuichiro
- Tanaka, Koji
- Kawachi, Hiroshi
- Shirakawa, Yasuhiro
- Kitagawa, Yuko
- Toh, Yasushi
- Yasuda, Takushi
- Watanabe, Masayuki
- Kamei, Takashi
- Oyama, Tsuneo
- Seto, Yasuyuki
- Murakami, Kentaro
- Arai, Tomio
- Muto, Manabu
- Mine, Shinji
- SpringerLink (Online service)
Ähnliche Objekte (12)
Japanese Classification of Esophageal Cancer, 12th Edition: Part I
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Validation of new Japanese classification system for esophageal achalasia
A survey of mental health literacy in Japanese high school teachers
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
Japanese Classification of Esophageal Cancer, 12th Edition: Part I
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Validation of new Japanese classification system for esophageal achalasia
A survey of mental health literacy in Japanese high school teachers
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
Japanese Classification of Esophageal Cancer, 12th Edition: Part I
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Validation of new Japanese classification system for esophageal achalasia
A survey of mental health literacy in Japanese high school teachers
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society